Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02228031

Oxytocin, Emotions and Mirror Neurons

The Influence of Oxytocin on the Mirror Neuron System: Developing Brain Imaging Paradigms for Future Therapeutic Interventions

Sponsor: University of Maryland, Baltimore

Conditions Expressed Emotion Social Cognition

Interventions Oxytocin Placebo

Updated 8 times since 2017 Last updated: Aug 15, 2019 Started: Oct 31, 2014 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Expressed Emotion and Social Cognition and is currently completed. University of Maryland, Baltimore leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Sep 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Sep 2019 [monthly]

Completed EARLY_PHASE1

▶ Show 3 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Status: Unknown Status → Completed
Feb 2017 — Sep 2017 [monthly]

Unknown Status EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status Phase 0

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Maryland, Baltimore
University of Maryland, College Park

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• College Park, United States